{"id":"migraine-relief","safety":{"commonSideEffects":[{"rate":null,"effect":"Skin irritation at application site"},{"rate":null,"effect":"Mild discomfort during stimulation"},{"rate":null,"effect":"Headache"}]},"_chembl":null,"_fixedAt":"2026-03-30T17:50:13.699698","_dailymed":{"setId":"efbfd58c-f3a6-4734-a37f-9f58fded990a","title":"HEADACHE AND MIGRAINE RELIEF (BELLADONNA, BRYONIA, CAPSICUM ANNUUM, GELSEMIUM, GLONOINUM, IGNATIA AMARA, KALI BICHROMICUM, KALI CARBONICUM, LYCOPODIUM, NATRUM MURIATICUM, NICCOLUM METALLICUM, NUX VOMICA, SANGUINARIA, SECALE CORNUTUM, SPIGELIA ANTH AND SULPHUR.) LIQUID [KING BIO INC.]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The device uses transcutaneous electrical nerve stimulation (TENS) applied to the forehead to modulate trigeminal nerve activity, which is implicated in migraine pathophysiology. By delivering targeted electrical pulses, it aims to reduce migraine frequency, duration, and severity through non-pharmacological neuromodulation.","oneSentence":"Migraine Relief is a wearable neuromodulation device that delivers electrical stimulation to the trigeminal nerve to prevent or treat migraine headaches.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T02:01:29.637Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Migraine prevention"},{"name":"Acute migraine treatment"}]},"_fixedFields":["pubmed(96)"],"trialDetails":[{"nctId":"NCT04396236","phase":"PHASE3","title":"A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine","status":"TERMINATED","sponsor":"Eli Lilly and Company","startDate":"2020-06-15","conditions":"Migraine","enrollment":851},{"nctId":"NCT06716489","phase":"NA","title":"Aerobic Exercise and Its Impact on Sensory, Musculoskeletal, and Psychosocial Aspects in Migraine","status":"RECRUITING","sponsor":"University of Sao Paulo","startDate":"2026-03-03","conditions":"Migraine, Migraine Disease, Migraine Disorder","enrollment":100},{"nctId":"NCT05979337","phase":"NA","title":"Brief Interventions in Chronic Migraine","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Michigan","startDate":"2023-10-11","conditions":"Chronic Migraine","enrollment":300},{"nctId":"NCT07373275","phase":"NA","title":"Adolescent Lifestyle Medicine Headache Study","status":"NOT_YET_RECRUITING","sponsor":"MaineHealth","startDate":"2026-03","conditions":"Headache, Migraine","enrollment":50},{"nctId":"NCT07360405","phase":"NA","title":"Dietary Intervention for Migraine Relief","status":"NOT_YET_RECRUITING","sponsor":"American University","startDate":"2026-01","conditions":"Migraine","enrollment":40},{"nctId":"NCT05334927","phase":"","title":"China HeadAche DIsorders RegiStry","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2022-08-29","conditions":"Headache Disorders, Primary, Migraine, New Daily Persistent Headache","enrollment":10000},{"nctId":"NCT07297901","phase":"NA","title":"App-based Breathing Program for Migraine Relief","status":"ENROLLING_BY_INVITATION","sponsor":"Arizona State University","startDate":"2025-12-15","conditions":"Migraine, Heart Rate Variability (HRV), Autonomic Nervous System","enrollment":30},{"nctId":"NCT05464069","phase":"","title":"Safety of Nerivio in Pregnant Women With Migraine","status":"COMPLETED","sponsor":"Theranica","startDate":"2022-08-01","conditions":"Migraine, Pregnancy Related","enrollment":145},{"nctId":"NCT06267924","phase":"NA","title":"SENSE-VM: Safety and Effectiveness of a Novel Medical Device for Symptom Ease in Vestibular Migraines","status":"COMPLETED","sponsor":"Otolith Labs","startDate":"2024-03-06","conditions":"Vestibular Migraine, Migraine Associated Vertigo","enrollment":322},{"nctId":"NCT04100135","phase":"NA","title":"GORE® CARDIOFORM Septal Occluder Migraine Clinical Study","status":"TERMINATED","sponsor":"W.L.Gore & Associates","startDate":"2021-02-05","conditions":"Migraine, Patent Foramen Ovale, PFO - Patent Foramen Ovale","enrollment":7},{"nctId":"NCT06504537","phase":"NA","title":"Comparative Effects of Theragun Percussion Therapy and Compression Therapy in The Patients With Migraine","status":"RECRUITING","sponsor":"Riphah International University","startDate":"2024-01-01","conditions":"Migraine","enrollment":50},{"nctId":"NCT02695498","phase":"NA","title":"Mindfulness and Mechanisms of Pain Processing in Adults With Migraines","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2016-08-26","conditions":"Migraine","enrollment":89},{"nctId":"NCT03263897","phase":"NA","title":"Feasibility of Using a Mobile Device Controlled Micro-pressure Pulse Insufflator for Acute Migraine Relief","status":"TERMINATED","sponsor":"Caps Research Network","startDate":"2017-08-21","conditions":"Migraine","enrollment":59},{"nctId":"NCT04660864","phase":"NA","title":"Nasal Cavity Cooling for the Symptomatic Relief of Migraine Headache - a Pilot Study","status":"COMPLETED","sponsor":"Lund University","startDate":"2021-03-03","conditions":"Migraine","enrollment":15},{"nctId":"NCT02344316","phase":"PHASE2","title":"Bringing Relief to Adolescents Naturally Using Melatonin for Migraine","status":"COMPLETED","sponsor":"Amy Gelfand","startDate":"2015-05","conditions":"Migraine in Adolescents","enrollment":31},{"nctId":"NCT01197196","phase":"NA","title":"Behavioral Weight Loss as a Treatment for Migraine in Obese Women","status":"COMPLETED","sponsor":"The Miriam Hospital","startDate":"2012-06","conditions":"Migraine, Obesity","enrollment":112},{"nctId":"NCT02169830","phase":"NA","title":"Trial of Nortriptyline and Topiramate in the Initial Treatment of Vestibular Migraine","status":"TERMINATED","sponsor":"St. Louis University","startDate":"2014-08-22","conditions":"Migraine Disorders","enrollment":35},{"nctId":"NCT04066426","phase":"PHASE4","title":"Efficacy of Naproxen-codeine, Naproxen+Dexamethasone, and Naproxen on Myofascial Pain","status":"COMPLETED","sponsor":"Yuzuncu Yil University","startDate":"2018-03-01","conditions":"Temporomandibular Disorder","enrollment":200},{"nctId":"NCT01859481","phase":"PHASE3","title":"Eletriptan Provides Consistent Migraine Relief: Results Of A Within-Patient Multiple-Dose Study","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2000-03","conditions":"Migraine Without Aura, Migraine With Aura","enrollment":971},{"nctId":"NCT03167060","phase":"NA","title":"BrainCool-Migraine Intranasal Cooling Trial","status":"COMPLETED","sponsor":"Cumbria Partnership NHS Foundation Trust","startDate":"2017-05-08","conditions":"Migraine","enrollment":90},{"nctId":"NCT00483704","phase":"PHASE3","title":"Multiple Attacks Study to Compare the Efficacy and Safety of MK-0974 With Placebo for Acute Migraine (MK-0974-031)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2008-08-14","conditions":"Migraines","enrollment":1935},{"nctId":"NCT03410628","phase":"NA","title":"Non-invasive Neurostimulation for the Relief of Migraine","status":"TERMINATED","sponsor":"ElectroCore INC","startDate":"2011-07","conditions":"Migraine","enrollment":21},{"nctId":"NCT01532830","phase":"NA","title":"Non-Invasive Neurostimulation For the Relief of Symptoms Associated With Migraine","status":"COMPLETED","sponsor":"ElectroCore INC","startDate":"2012-02","conditions":"Migraine","enrollment":30},{"nctId":"NCT02549885","phase":"NA","title":"Efficacy of Proprioceptive Neuromuscular Facilitation in Pain Relief","status":"COMPLETED","sponsor":"Universidade Federal de Pernambuco","startDate":"2016-04","conditions":"Migraine Disorders","enrollment":30},{"nctId":"NCT02453399","phase":"NA","title":"Relief of Migraine Pain Through Electro Stimulation","status":"COMPLETED","sponsor":"Theranica","startDate":"2015-07","conditions":"Migraine Headache","enrollment":87},{"nctId":"NCT02075489","phase":"NA","title":"Acupressure for Pain Management and Fatigue Relief in Gulf War Veterans","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2012-09","conditions":"Persian Gulf Syndrome, Chronic Fatigue Syndrome","enrollment":7},{"nctId":"NCT02777359","phase":"PHASE2","title":"Precutaneous High Risk Patent Foramen Ovale to Treat Migraine Headaches","status":"UNKNOWN","sponsor":"First Affiliated Hospital Xi'an Jiaotong University","startDate":"2017-01","conditions":"Patent Foramen Ovale","enrollment":100},{"nctId":"NCT02375789","phase":"NA","title":"Intranasal Cooling for Symptomatic Relief of Migraine","status":"TERMINATED","sponsor":"Cumbria Partnership NHS Foundation Trust","startDate":"2015-10","conditions":"Migraine Headache","enrollment":27},{"nctId":"NCT01287052","phase":"NA","title":"Nitrous Oxide for Acute Migraine Pain in the Emergency Room (ED)","status":"COMPLETED","sponsor":"Children's Hospitals and Clinics of Minnesota","startDate":"2011-06","conditions":"Migraine, Pain","enrollment":30},{"nctId":"NCT01898455","phase":"NA","title":"Intranasal Cooling for Cluster Headache and Migraine","status":"COMPLETED","sponsor":"Cumbria Partnership NHS Foundation Trust","startDate":"2013-08","conditions":"Migraine, Cluster Headache","enrollment":15},{"nctId":"NCT00417742","phase":"NA","title":"Project CHEER (Comprehensive Headache Evaluation, Education, Relief)","status":"COMPLETED","sponsor":"Duke University","startDate":"2002-06","conditions":"Chronic Headache","enrollment":828},{"nctId":"NCT01653340","phase":"NA","title":"A Feasibility Clinical Trial to Evaluate High Frequency Spinal Cord Stimulation for the Treatment of Patients With Chronic Migraine","status":"COMPLETED","sponsor":"University of Roma La Sapienza","startDate":"2012-05","conditions":"Refractory Chronic Migraine","enrollment":18},{"nctId":"NCT01135784","phase":"PHASE2","title":"Study of MIGRA-ZEN RELIEF PLUS In the Treatment of Chronic Migraine Headache","status":"UNKNOWN","sponsor":"RZN Nutraceuticals, Inc.","startDate":"2011-10","conditions":"Chronic Migraine","enrollment":30}],"_emaApprovals":[],"_faersSignals":[{"count":8,"reaction":"DRUG INEFFECTIVE"},{"count":5,"reaction":"NAUSEA"},{"count":4,"reaction":"HEADACHE"},{"count":4,"reaction":"INCORRECT DOSE ADMINISTERED"},{"count":4,"reaction":"PNEUMONIA"},{"count":4,"reaction":"PRODUCT USE IN UNAPPROVED INDICATION"},{"count":3,"reaction":"ABDOMINAL DISCOMFORT"},{"count":3,"reaction":"DRUG EFFECTIVE FOR UNAPPROVED INDICATION"},{"count":3,"reaction":"DRY MOUTH"},{"count":3,"reaction":"FEELING ABNORMAL"}],"_approvalHistory":[{"date":"20120427","type":"SUPPL","sponsor":"BIONPHARMA","applicationNumber":"ANDA078682"},{"date":"20130312","type":"SUPPL","sponsor":"BIONPHARMA","applicationNumber":"ANDA078682"},{"date":"20190221","type":"SUPPL","sponsor":"BIONPHARMA","applicationNumber":"ANDA078682"},{"date":"20090324","type":"ORIG","sponsor":"BIONPHARMA","applicationNumber":"ANDA078682"},{"date":"20191112","type":"SUPPL","sponsor":"BIONPHARMA","applicationNumber":"ANDA078682"},{"date":"20130731","type":"SUPPL","sponsor":"BIONPHARMA","applicationNumber":"ANDA078682"},{"date":"20190221","type":"SUPPL","sponsor":"BIONPHARMA","applicationNumber":"ANDA078682"},{"date":"20020816","type":"SUPPL","sponsor":"PERRIGO","applicationNumber":"ANDA075794"},{"date":"20101122","type":"SUPPL","sponsor":"PERRIGO","applicationNumber":"ANDA075794"},{"date":"20061121","type":"SUPPL","sponsor":"PERRIGO","applicationNumber":"ANDA075794"},{"date":"20031217","type":"SUPPL","sponsor":"PERRIGO","applicationNumber":"ANDA075794"},{"date":"20011126","type":"ORIG","sponsor":"PERRIGO","applicationNumber":"ANDA075794"},{"date":"20160226","type":"SUPPL","sponsor":"PERRIGO","applicationNumber":"ANDA075794"},{"date":"20020816","type":"SUPPL","sponsor":"PERRIGO","applicationNumber":"ANDA075794"},{"date":"20020816","type":"SUPPL","sponsor":"PERRIGO","applicationNumber":"ANDA075794"},{"date":"20031008","type":"SUPPL","sponsor":"PERRIGO","applicationNumber":"ANDA075794"},{"date":"20080305","type":"SUPPL","sponsor":"PERRIGO","applicationNumber":"ANDA075794"},{"date":"20020816","type":"SUPPL","sponsor":"PERRIGO","applicationNumber":"ANDA075794"},{"date":"20141212","type":"SUPPL","sponsor":"PERRIGO","applicationNumber":"ANDA075794"},{"date":"20040827","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA020802"},{"date":"20030521","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA020802"},{"date":"20020419","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA020802"},{"date":"20000426","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA020802"},{"date":"19990820","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA020802"},{"date":"20230417","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA020802"},{"date":"19981022","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA020802"},{"date":"20160128","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA020802"},{"date":"20100204","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA020802"},{"date":"20190415","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA020802"},{"date":"20140730","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA020802"},{"date":"20171012","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA020802"},{"date":"20070131","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA020802"},{"date":"20001010","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA020802"},{"date":"20211103","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA020802"},{"date":"20000907","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA020802"},{"date":"19991007","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA020802"},{"date":"20160429","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA020802"},{"date":"20230515","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA020802"},{"date":"20200227","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA020802"},{"date":"20151117","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA020802"},{"date":"20211207","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA020802"},{"date":"20180102","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA020802"},{"date":"19980114","type":"ORIG","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA020802"},{"date":"20140715","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA020802"},{"date":"20170913","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA020802"},{"date":"20140415","type":"SUPPL","sponsor":"HALEON US HOLDINGS","applicationNumber":"NDA020802"},{"date":"20220202","type":"ORIG","sponsor":"AUROBINDO PHARMA LTD","applicationNumber":"ANDA211695"},{"date":"20210223","type":"ORIG","sponsor":"GRANULES","applicationNumber":"ANDA214039"}],"publicationCount":96,"recentPublications":[{"date":"2025 Dec","pmid":"41675281","title":"Metabolomics Reveals Reasons for the Efficacy of Acupuncture in Migraine Patients: The Role of Anaerobic Glycolysis and Mitochondrial Citrate in Migraine Relief.","journal":"Phenomics (Cham, Switzerland)"},{"date":"2026 Feb 10","pmid":"41667679","title":"Effects of adding transcutaneous vagus nerve stimulation to vestibular rehabilitation on dizziness and postural control in vestibular migraine: a randomized clinical trial.","journal":"Scientific reports"},{"date":"2026","pmid":"41574090","title":"Investigation of the rimegepant effect on cerebral and extracerebral arteries during migraine attacks: a longitudinal magnetic resonance angiography study.","journal":"Brain communications"},{"date":"2025 Dec 21","pmid":"41422534","title":"Systematic review and meta-analysis of Tanacetum parthenium: evaluating its efficacy in migraine relief.","journal":"Natural product research"},{"date":"2025","pmid":"41357877","title":"Gepants: targeting the CGRP pathway for migraine relief.","journal":"Frontiers in pharmacology"}],"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["migraine treatment"],"phase":"marketed","status":"active","brandName":"Migraine Relief","genericName":"Migraine Relief","companyName":"Theranica","companyId":"theranica","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Migraine Relief is a wearable neuromodulation device that delivers electrical stimulation to the trigeminal nerve to prevent or treat migraine headaches. Used for Migraine prevention, Acute migraine treatment.","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"supplemented","approval_date":"1998-01-14T00:00:00.000Z","mah":"HALEON US HOLDINGS","brand_name_local":null,"application_number":"NDA020802"},{"country_code":"US","regulator":"FDA","status":"supplemented","approval_date":"2001-11-26T00:00:00.000Z","mah":"PERRIGO","brand_name_local":null,"application_number":"ANDA075794"},{"country_code":"US","regulator":"FDA","status":"supplemented","approval_date":"2009-03-24T00:00:00.000Z","mah":"BIONPHARMA","brand_name_local":null,"application_number":"ANDA078682"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2021-02-23T00:00:00.000Z","mah":"GRANULES","brand_name_local":null,"application_number":"ANDA214039"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2022-02-02T00:00:00.000Z","mah":"AUROBINDO PHARMA LTD","brand_name_local":null,"application_number":"ANDA211695"}],"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}